Background: Adjustments in intestinal absorption and losses of zinc (Zn) are thought to maintain Zn homeostasis when dietary intake levels are altered. Zn status may also influence efficiency of intestinal Zn absorption. Objectives: To determine the impact of dietary intake and status of some micronutrients on Zn absorption in late middle-aged men. Design and participants: Dietary intake and status of Zn, Cu, Fe, vitamin A, C and fibre, and absorption of Zn were measured in 48 men, aged 58-68 y, confined to a metabolic unit and consuming a typical French diet. Dietary intake was estimated using 4-day food-intake records (including the weekend) and the GENI program. To assess Zn status, serum, erythrocyte, urine Zn levels and serum alkaline phosphatase activity were determined. Zn absorption was determined using the isotope doublelabelling method. Zn stable isotopic ratios were measured in plasma samples collected before and 48 h after isotope administration using ICP/MS. Results: Zn intake within the group of men varied from 5.7 to 20.5 mg/day and averaged 12.9 mg/day. Serum Zn level varied from 10 to 18 mmol/l and averaged 12.9 mmol/l. Zn absorption varied from 12 to 46% and averaged 29.7%. Zn absorption was not significantly (P40.05) correlated with Zn intake or with any of the Zn status parameters. Zn absorption was only slightly negatively correlated with serum and erythrocyte Zn levels and with serum Fe and ferritin levels in this study. Conclusion: Zn dietary intake and Zn absorption were satisfactory and led to an adequate Zn status in this population.
Introduction
The role of zinc (Zn) in human biology and human health is now well known (Prasad, 1998) . More than 300 enzymes, including all six enzyme classes, and several hormones are known to be Zn dependent. Thus, Zn is needed for growth and development, protein and DNA synthesis, neuro-sensory functions, cell-mediated immunity, thyroid and bone metabolism (Vallee & Falchuk, 1993) . It is well recognized that Zn intake data alone do not provide information on Zn nutritional status. Such information can be obtained when these Zn intake data are combined with intestinal absorption *Correspondence: C Coudray, Unité Maladies Métaboliques et Micronutriments, I .N.R.A., Theix, Saint Genès Champanelle 63122, France. E-mail: coudray@clermont.inra.fr Guarantor: C Coudray. Contributors: NM recruited Zenith subjects, CFC handled the results, MAS contributed to Zn measurement, MR performed stable isotope determination, MB determined dietary intakes, SJC Cupper measurement, KDC performed analysis of urinary creatinine and manuscript correction, CC performed study design and paper writing and coordinated ZENITH Study. All authors read and contributed to finalization of the manuscript. rate and other biochemical and anthropometric information. Marginal Zn deficiency and suboptimal Zn status have been observed in many population groups in both less developed and industrialized countries (Prasad, 1985; Galal, 2000) . Although the cause in some cases may be inadequate dietary intake of Zn, inhibitors of Zn absorption are most likely the most common causative factor (Lonnerdal, 2000) . Many staple foods are relatively rich in Zn and net Zn intake from such foods may appear adequate in relation to most dietary Zn recommendations. However, Zn absorption from many foods is limited and compromised Zn status is common (Gibson & Ferguson, 1998) . It is therefore important to identify and evaluate dietary factors that affect Zn absorption in human. Identification of such dietary factors may enable individuals to avoid or limit components with inhibitory effects on Zn absorption and to choose foods or dietary components that may enhance Zn absorption. In this study, efficiency of intestinal Zn absorption in 48 men, aged between 55 and 70 y, was determined using the isotope double-labelling technique and the absorption efficiency estimates correlated with both dietary Zn intake and Zn status parameters, as well as with other factors expected to influence Zn absorption.
Subjects and methods

Subjects
A total of 48 healthy male subjects, aged 58-68 y, participated in this study and before beginning the study each underwent a clinical examination, which was carried out by the medical staff at the Unit of Nutritional Exploration in Clermont-Ferrand, France. These subjects belong to the overall Zenith study cohort. The subjects were nonsmokers and judged to be healthy. None of the selected subjects took vitamin/mineral supplements or medications which might have affected Zn metabolism. Dietary Zn intake was estimated using 4-day food-intake records (including weekend). The dietary data were checked with a dietician, using a specific picture book for the estimations of quantities (SU.VI.MAX., Portions alimentaires, Polytechnica editions, Paris, 1994), which has been validated (Le Moullec et al, 1996) . Nutrient intakes were estimated using the dietetics software 'Geni' (Gestion des Enquêtes Nutritionnelles Informatisée, Micro6, Villers-lès-Nancy, France), whose table composition is derived from REGAL (Favier et al, 1995) .
Ethical considerations
The study was approved by the local Human Ethical Committee in Clermont-Ferrand under number AU 478 (CCPPRB Auvergne). All participants were fully informed of the purposes of the study and gave their written, informed consent. Zn stable isotope solution were prepared by the hospital pharmacist (Clermont-Ferrand University Hospital Center, France). Briefly, the ZnO isotopes were first moistened with milliQ water and then concentrated HCl (12 N) was added gradually with stirring to completely transform the oxide form into the chloride form. The solution volume was then adjusted with water containing 0.9% NaCl. This solution was gradually neutralized with 6 ml of 1 N NaOH to reach a pH between 4 and 7. The solution was then adjusted with water containing 0.9% NaCl and filtered on a 0.22 mm filter and autoclaved. The pharmaceutical quality of the stable isotope solutions was certified by the Clermont-Ferrand Hospital pharmacy. The Zn concentration and the 70 Zn and
67
Zn isotopic enrichments of the prepared solutions were checked on inductively coupled plasma mass spectrometry (ICP/MS) in our laboratory before use.
Administration of tracer solutions
The subjects were admitted to the Human Nutrition Unit of Clermont-Ferrand after an overnight fast. The subjects were confined to a metabolic unit and consumed at lunch a typical French diet low in Zn. Fasted blood and urine samples were collected on the morning before the isotopic administration. Each subject received orally about 3.6 mg of 67 Zn and an intravenous catheter was inserted into the left arm of each subject. After 30 min, about 0.85 mg of 70 Zn in 15 ml saline (0.9% NaCl) solution was perfused over 2 min. A fasten blood sample was obtained 48 h after isotope administration for stable isotopic ratios measurement and intestinal Zn absorption determination.
Biological analysis
Blood samples were collected in Zn-free dry or heparinized tubes and centrifuged (1000 g, 15 min, þ 41C) and the serum or plasma, respectively, were separated. Erythrocytes were washed with saline solution and hemolysed. Urine was acidified with pure HCl (final acid concentration: 1%). Samples were then stored at À201C until analysis. The Prior to analysis, the plasma was diluted in 0.014 M HNO 3 . Natural Zn and indium (SPEX Claritas) were used as external and internal standards, respectively. For total Zn determination, plasma and urine were diluted in 0.1 M HCl (1 vol/ 5 vol) and erythrocytes were diluted in deionized water (1 vol/100 vol). Zn concentration was then determined on a flame atomic absorption spectrophotometer (AA800, Perkin-Elmer, Paris, France) at 214 nm. Urinary creatinine concentrations were measured by colorimetry (Hill et al, 2005) . Serum Fe, ferritin, transferrin saturation, Cu and serum phosphatase alkaline and red blood cell superoxide dismutase as well as urinary creatinine concentrations were measured as described elsewhere in this issue (AndriolloSanchez et al, 2005; Hill et al, 2005) . Figure 1 ). The five quintiles of Zn absorption were also calculated: 1st quintile: 17.57 3.8%; 2nd quintile: 24.071.1%; 3rd quintile: 28.871.7%; 4th quintile: 35.172.5%; 5th quintile: 43.271.7%. Zn absorption was not significantly (P40.05) correlated with Zn intake and was not significantly correlated with serum or erythrocyte Zn levels and with serum Fe and ferritin levels (data not shown). However, when Zn absorption values have been divided into five quintiles, we found that subject height and dietary Zn, fibre and energy intakes were significantly higher in the 5th quintile than in the 1st quintile of Zn absorption (Po0.05). As shown in Figure 2 , Zn absorption was significantly and positively correlated with the height of subjects (r ¼ þ 0.344, P ¼ 0.017; n ¼ 48). Figure 2 Regression correlation between intestinal Zn absorption and subject height determined in 48 men aged 55-70 y. Intestinal Zn absorption was determined on plasma samples collected 48 h after stable isotope administration ( 67 Zn orally and 70 Zn intravenously). For more details, see Table 1 legend.
Statistical analyses
Discussion
In order to assess the nutritional importance of Zn, it is relevant to consider the factors regulating its metabolism, including Zn intake level, Zn absorption and Zn utilization. The absorption of Zn depends on its chemical form as well as the concentration of other dietary constituents such as fibre, phytate, vitamins and other minerals in the diet (Abdulla et al, 1989; Gibson & Ferguson, 1998) . Knowledge of these interactions are important to improve the overall nutritional Zn status of the population in general and in patients in particular. Zn absorption was determined in this study on a large number of subjects (n ¼ 48) using a robust isotopic technique based on the double-labelling approach (Hambidge et al, 1998; Fairweather-Tait & Dainty, 2002; Werner et al, 2002) . The estimates of efficiency of intestinal Zn absorption (29.779.0%) obtained in this study is close to those generally reported in the literature (Sandstrom, 1995; Ducros et al, 2005) . Interindividual variation was about 30% which is in agreement with previous published results on Zn absorption measured by isotopic approaches (Ducros et al, 2005) . Such variability depends on both the physiological state of the subjects and the isotope administration and measurement conditions. Administration of low amounts of isotopes yields low plasma isotopic enrichment and thus less precision in isotope analysis which, in turn, increases the absorption variability. In this study, about 3.6 mg of 67 Zn were orally administered and plasma 67 Zn enrichments between 3 and 16% were obtained. The low plasma 67 Zn enrichments in some subjects (o6%) in the present study may contribute to this high absorption variability.
Zn absorption did not correlate significantly with the dietary intake of any of the selected micronutrients estimated in this study. At least two hypotheses may explain these results. Firstly, several uncertainties in the assessment of dietary intake alter the precision of dietary intake estimation of many micronutrients. Indeed, we recorded the quantity of food consumed by the subjects over 4 days including the weekend but this remains very much an approximation and may not reflect the habitual intake by subjects over weeks and months (Gibson & Ferguson, 1998) . Moreover, the food composition tables are generally incomplete for many foods, especially in relation to some micronutrients, in particular Zn and Cu. Secondly, the other plausible hypothesis that may explain the lack of correlation between Zn absorption and dietary Zn intake is that Zn homeostasis mechanisms are efficient at the level of the endogenous Zn excretion, which increases or decreases according to Zn dietary intake and body requirement (King, 1986; King et al, 2000; Krebs, 2000) . Unfortunately, we did not measure endogenous Zn excretion in faeces in this study.
Assessment of Zn status of individuals and populations is also very difficult (Hotz et al, 2003) . In this study, we measured four Zn status parameters: serum, erythrocyte and urine Zn levels and serum ALP activity. All these parameters were in the normal ranges usually reported in the literature for this population group (Giles et al, 1994) . Thus, the subjects in the present study, aged 55-70 y, appeared to have satisfactory Zn status. Zn absorption was not significantly correlated with any of the Zn status parameters. There was only a trend for a negative correlation between Zn absorption and serum and erythrocyte Zn levels (r ¼ À0.176, À0.120, respectively). It may be that this very weak correlation is indicative of the fact that our subjects had adequate Zn status and thus Zn absorption was not affected by this status. Effectively, Zn absorption is expected to be affected in high or low Zn status where the absorption is modulated to maintain Zn status in narrow values (Johnson et al, 1993; Sian et al, 1996) . Moreover, Zn absorption was not significantly correlated with any of Fe or Cu status measured in this study; Fe or Cu status also appeared to be adequate in our subjects. Finally, Zn absorption was significantly and positively correlated with subject height (Figure 2) . This is the first report, to the authors knowledge, of an association between height and Zn absorption.
In conclusion, Zn dietary intake, Zn status and Zn absorption were satisfactory in this population. Neverthless, better techniques for assessing dietary intake and more complete food compositional tables are needed. Further research on a group with a greater sample size is needed to determine the possible impact of dietary intake of each micronutrient in the meal on Zn absorption in human.
